AI isn't close to curing cancer. This startup says it knows what it will take. | TechCrunch · AuraTracer

SummaryAI generated

On August 19, 2026, TechCrunch reported that artificial intelligence is still far from curing cancer. A startup claimed to have a clear understanding of the key steps needed to achieve this goal. The report emphasized that current AI technologies have not yet made breakthroughs in cancer treatment, but related companies have already gained preliminary insights into specific implementation approaches.

Related eventsRELATED EVENTS

2026-09-09 05:29OpenAI claims huge maths breakthrough on a famed ‘Millennium Problem’
2026-09-09 06:11OpenAI claims to have solved the Navier-Stokes equation problem, but its originality is questioned by the academic community
2026-09-08 22:00Google DeepMind Maps 9 Billion Possible DNA Variants

Key entitiesKEY ENTITIES

Andre GeorgescuDario AmodeiDemis HassabisSam AltmanVivodyne

Coverage · reports per dayLANGUAGE SPLIT

Entity relations

SignalsSIGNALS

Keyword heat

Vivodyne1
Andre Georgescu1
Dario Amodei1
Sam Altman1
Demis Hassabis1

All reports (1)SOURCES

↗

T TechCrunch 归档 8月 p08 en 2026-08-19 08:00

AI isn't close to curing cancer. This startup says it knows what it will take. | TechCrunch

生物科技公司 Vivodyne 称 AI 药物研发存在数据缺失问题，其自主研发的模块化机器人实验室 HIVE 可自主培养 20 种人源组织并监测。Vivodyne 首席执行官 Andrey Georgescu 指出，现有 AI 模型因缺乏人体测试数据，目前仅能验证小鼠实验结果，无法解决癌症等复杂疾病。尽管 AlphaFold 等成果显著，但实际新药产出寥寥，且动物实验成功率与临床获批率存在巨大落差。Vivodyne 声称其组织在毒性预测、气道行为及化疗药物一致性测试中分别达到 94%、96% 和 100% 的准确度，并已建成全球最大“人体数据中心”，旨在通过高质量人体数据加速药物筛选进程。